Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARPEGGIO: POSLUMA-guided Intra-prostatic Boost for Prostate Cancer
NCT07393867Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flotufolastat f 18 in prostate cancer (PCa). Started Apr 2026; status: recruiting.
02
Drugs
flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07393867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393867.